Radiopharm Theranostics (RADX) Total Debt (2024 - 2025)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Radiopharm Theranostics (RADX) has disclosed Total Debt for 2 consecutive years, with $32.1 million as the latest value for Q2 2025.

• Quarterly Total Debt fell 3.97% to $32.1 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $32.1 million through Jun 2025, down 3.97% year-over-year, with the annual reading at $32.1 million for FY2025, 3.97% down from the prior year.
• Total Debt for Q2 2025 was $32.1 million at Radiopharm Theranostics, down from $33.4 million in the prior quarter.
• The five-year high for Total Debt was $33.4 million in Q2 2024, with the low at $32.1 million in Q2 2025.

Peer Comparison